Merck Global Health Innovation Fund

Funding rounds backed by Merck Global Health Innovation Fund.

Export CSV
Funding disclosed in full
$75M
Median round
$75M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Infinimmune

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries ABiotechUnited States
11 participantsCivilization VenturesEverbright BiofundForge Life Science PartnersGodfrey CapitalGoldcrest CapitalMerck Global Health Innovation FundPear VCPlayground GlobalRA Capital ManagementRegeneron VenturesWild Tree Ventures
DropGenie

Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery

UndisclosedSeed+BiotechCanada
5 participantsAnges QuébecCQDMMerck Global Health Innovation FundReal VenturesSkeleton Key